Related Experiment Videos
Productive syntax abilities in Huntington's and Parkinson's diseases
1Department of Speech and Hearing Sciences, Indiana University, USA.
Brain and Cognition
|August 31, 2001
Summary
Patients with Huntington's disease (HD) show significant syntactic changes, using shorter and less complete sentences. These language deficits in HD and Parkinson's disease (PD) are linked to cognitive and motor impairments.
Area of Science:
- Neurolinguistics
- Neurodegenerative Diseases
- Speech-Language Pathology
Background:
- Huntington's disease (HD) and Parkinson's disease (PD) are subcortical neurodegenerative disorders.
- Language production, specifically syntax, may be affected in these conditions.
- Understanding these changes is crucial for diagnosis and management.
Purpose of the Study:
- To investigate syntactic alterations in the spoken discourse of patients with HD and PD.
- To explore the relationship between syntactic changes and cognitive/motor symptoms in HD and PD patients.
- To differentiate language profiles between HD, PD, and healthy controls.
Main Methods:
- Participants included patients with HD, patients with PD, and age-matched healthy controls.
- Spoken discourse was analyzed during a conversational activity.
- Standardized speech and cognitive tests were administered.
- Syntactic complexity and utterance completeness were assessed.
Main Results:
- The HD group exhibited significantly shorter and less grammatically complete utterances compared to controls.
- No significant syntactic differences were found between PD patients and controls, or between PD and HD patients.
- Productive syntax abilities in both HD and PD correlated with neuropsychological and motor speech changes.
Conclusions:
- Patients with Huntington's disease may experience language production deficits, specifically in syntax.
- These syntactic deficits in HD are likely influenced by both motor speech impairments (dysarthria) and cognitive decline.
- Further research is needed to fully elucidate the language profiles in subcortical neurodegenerative diseases.